California State Teachers Retirement System (CalSTRS)’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
SOCM
BBA
TECP
VC
California State Teachers Retirement System (CalSTRS)'s DSGN Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Design Therapeutics (DSGN) stake by 74% in Q2 2026, selling an estimated $11.9K and leaving 335 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2561.
California State Teachers Retirement System (CalSTRS) first reported a position in DSGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $370K in Q2 2021. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 335 shares of Design Therapeutics worth $4.85K as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) sold 957 Design Therapeutics shares in Q2 2026, an estimated $11.9K.
- Design Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2561 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Design Therapeutics in Q2 2021 and has held it in 20 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Design Therapeutics position peaked at $370K in Q2 2021.
- 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.